UPDATE: Melinta Therapeutics (MLNT) Misses Q2 EPS by 48c, Revenues Beat
Tweet Send to a Friend
(Updated - August 9, 2019 7:40 AM EDT)
Melinta Therapeutics (NASDAQ: MLNT) reported Q2 EPS of ($3.07), $0.48 worse ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Melinta Therapeutics (NASDAQ: MLNT) reported Q2 EPS of ($3.07), $0.48 worse ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
